ASKA Pharmaceutical Holdings Co., Ltd.(JP:4886)
¥2,180.00+20.00 (+0.93%)
JP:4886
ASKA Pharmaceutical Holdings Co., Ltd. earnings date
¥2,180.00
At close:+20.00 (+0.93%)
Want to see JP:4886 full AI Analyst Report?
ASKA Pharmaceutical Holdings Co., Ltd. (4886) Q2 2024 Earnings Report
0 Followers
JP:4886 Q2 2024 EPS Results
- Actual EPS
- JPY 45.41
- Consensus EPS
- JPY 89.50
- Beat/Miss
- Missed by -JPY 44.09
- One Year Ago EPS
- JPY 95.42
JP:4886 Q2 2024 Revenue Results
- Actual Revenue
- JPY 16.02B
- Expected Revenue
- JPY 16.03B
- Beat/Miss
- Missed by -JPY 11.00M
- YoY Revenue Growth
- +2.52%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 11/05/2024
- Time
- TBA
- Conference Call
- Tuesday, November 5, 2024
JP:4886 Upcoming Earnings
ASKA Pharmaceutical Holdings Co., Ltd.'s next earnings date is estimated for February 8, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
JP:4886 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 08, 2027 | 2026 (Q3) | ―- | 59.1 | ― | ― |
| Nov 04, 2026 | 2026 (Q2) | ―51.85 | 34.61 | 49.81% (+17.24) | |
| Aug 04, 2026 | 2026 (Q1) | ―18.78 | 43.88 | -57.20% (-25.10) | |
| May 11, 2026 | 2025 (Q4) | ―53.53 | 35.36 | 51.39% (+18.17) | |
| Feb 02, 2026 | 2025 (Q3) | ―59.10 | 54.23 | 8.98% (+4.87) | |
| Nov 04, 2025 | 2025 (Q2) | ―34.61 | 45.41 | -23.78% (-10.80) | |
| Aug 04, 2025 | 2025 (Q1) | ―43.88 | 44.95 | -2.38% (-1.07) | |
| May 12, 2025 | 2024 (Q4) | ―35.36 | 38.37 | -7.84% (-3.01) | |
| Feb 03, 2025 | 2024 (Q3) | ―54.23 | 82.2 | -34.03% (-27.97) | |
| Nov 05, 2024 | 2024 (Q2) | 89.5045.41 | 95.42 | -52.41% (-50.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

